Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

This NCI-sponsored clinical trial evaluating EF5 and Motexafin Lutetium for detecting tumor cells in patients with abdominal cancers or non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Appendix
• Colon Cancer
• Gallbladder Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Epithelial Cancer
• Rectal Cancer

Drugs mentioned

• EF5
• Motexafin Lutetium

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | NA | Status: TERMINATED